Activella Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Conditions: Heavy Uterine Bleeding; Uterine FibroidsInterventions: Other: Placebo; Drug: Elagolix; Drug: Estradiol/norethindrone acetate, E2/NETA; Drug: Estradiol/norethindrone acetate, E2/NETA Dose 2; Other: Placebo; Drug: Elagolix; Drug: Estradiol/norethindrone acetate, E2/NETA; Drug: Estradiol/norethindrone acetateSponsor: AbbVieActive, not recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2013 Category: Research Source Type: clinical trials

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Conditions: Heavy Uterine Bleeding; Uterine FibroidsInterventions: Other: Placebo; Drug: Elagolix; Drug: Estradiol/norethindrone acetate, E2/NETA; Drug: Estradiol/norethindrone acetate, E2/NETA Dose 2; Other: Placebo; Drug: Elagolix; Drug: Estradiol/norethindrone acetate, E2/NETA; Drug: Estradiol/norethindrone acetateSponsor: AbbVieActive, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2013 Category: Research Source Type: clinical trials

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)
Conditions: Heavy Uterine Bleeding; Uterine FibroidsInterventions: Other: Placebo; Drug: Elagolix; Drug: Estradiol/norethindrone acetate, E2/NETA; Drug: Estradiol/norethindrone acetate, E2/NETA Dose 2; Other: Placebo; Drug: Elagolix; Drug: Estradiol/norethindrone acetate, E2/NETA; Drug: Estradiol/norethindrone acetateSponsor: AbbVieRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2013 Category: Research Source Type: clinical trials

Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
Conditions: Heavy Uterine Bleeding; Uterine FibroidsInterventions: Other: Placebo; Drug: Elagolix, elagolix sodium; Other: Placebo; Drug: Elagolix, elagolix sodium; Drug: Elagolix Dose 1 plus estradiol/norethindrone acetate; Other: Placebo; Drug: Elagolix, elagolix sodium; Drug: Elagolix, elagolix sodium; Drug: Elagolix, elagolix sodium; Drug: Elagolix Dose 2 plus estradiol; Drug: Elagolix Dose 2 plus cyclical progesteroneSponsor: AbbVie (prior sponsor, Abbott)Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 6, 2011 Category: Research Source Type: clinical trials

Endometrial Safety Study
Condition: PostmenopauseInterventions: Drug: 0.25mg DRSP / 0.5mg E2 (BAY86-4891); Drug: 0.5mg NETA / 1.0mg E2 (Activella)Sponsors: Bayer; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory; University of California, San FranciscoCompleted - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2007 Category: Research Source Type: clinical trials